Japan gives preliminary nod to first biosimilar G-CSF
This article was originally published in Scrip
Executive Summary
An advisory committee to Japan's ministry of health, ministry and welfare has recommended for approval the country's first biosimilar version of the recombinant granulocyte colony-stimulating factor (G-CSF) filgrastim.